The stock appears to be inexpensive relative to next year's earnings estimates and earnings growth expectations while having great near- and long-term earnings growth estimates. The company pays a great dividend and has a phenomenal return on equity. The risk/reward ratio is tilted towards higher risk at this point but it is about equal.
AbbVie Inc (NYSE:ABBV) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. On January 29, 2016, the company reported fourth quarter earnings of $1.13 per share which beat analyst estimates by $0.01. In the past year the company's stock is down 1% and is losing to the S&P 500, which has lost 0.3% in the same time frame.
Source: Seeking Alpha
Related Articles:
- 8 Select High-Yield S&P 500 Dividend Stocks
- A Winning Investment Strategy
- 7 Dividend Stocks With A 20% Yield In 20 Years
- 5 Industrial Strength Dividend Growth Stocks With Yields In Excess Of 3%
- Finding Low Risk Dividend Stocks
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.